Trial Profile
Option B+: ART Safety and Durability During First and Subsequent Pregnancies
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Efavirenz/lamivudine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms S4
- 10 Mar 2021 Status changed from active, no longer recruiting to completed.
- 26 May 2020 Planned End Date changed from 1 Jan 2020 to 1 Sep 2020.
- 26 May 2020 Planned primary completion date changed from 1 Jan 2020 to 1 Sep 2020.